Leonard S. Schleifer, Chief Executive Officer & President, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), sold 30,000 shares at $18.05 ($540K) on 2006-10-17, disclosed to the SEC on 2006-10-18.
Scheduled sale ($540k) by Chief Executive Officer & President, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 28,656 | $516K | 95.5% |
| 2 | $18.05 | 1,344 | $24K | 4.5% |
| Total | $18.00 avg | 30,000 | $540K | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |